Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

BUY
$40.4 - $59.1 $118,735 - $173,694
2,939 Added 1.21%
245,578 $9.99 Million
Q1 2023

Apr 24, 2023

BUY
$38.16 - $48.86 $2.29 Million - $2.93 Million
59,973 Added 32.83%
242,639 $11.8 Million
Q4 2022

Jan 20, 2023

SELL
$33.53 - $54.79 $6.62 Million - $10.8 Million
-197,423 Reduced 51.94%
182,666 $0
Q3 2022

Oct 28, 2022

SELL
$41.85 - $53.85 $3.85 Million - $4.95 Million
-91,889 Reduced 19.47%
380,089 $19.1 Million
Q2 2022

Jul 15, 2022

BUY
$25.6 - $45.23 $2.98 Million - $5.26 Million
116,317 Added 32.7%
471,978 $18.9 Million
Q1 2022

Apr 20, 2022

BUY
$33.33 - $44.6 $33 - $44
1 Added 0.0%
355,661 $13.3 Million
Q4 2021

Feb 03, 2022

SELL
$35.36 - $41.86 $89,566 - $106,031
-2,533 Reduced 0.71%
355,660 $14.2 Million
Q3 2021

Oct 19, 2021

SELL
$37.01 - $44.74 $882,503 - $1.07 Million
-23,845 Reduced 6.24%
358,193 $13.3 Million
Q2 2021

Aug 02, 2021

SELL
$37.95 - $49.37 $112,939 - $146,925
-2,976 Reduced 0.77%
382,038 $16.1 Million
Q1 2021

May 17, 2021

BUY
$46.8 - $68.92 $944,283 - $1.39 Million
20,177 Added 5.53%
385,014 $18.2 Million
Q4 2020

Feb 05, 2021

BUY
$47.96 - $67.64 $6.69 Million - $9.43 Million
139,482 Added 61.89%
364,837 $22.3 Million
Q3 2020

Nov 13, 2020

SELL
$45.41 - $57.07 $568,079 - $713,945
-12,510 Reduced 5.26%
225,355 $10.5 Million
Q2 2020

Aug 03, 2020

BUY
$42.56 - $54.98 $1.91 Million - $2.47 Million
44,912 Added 23.28%
237,865 $12.1 Million
Q1 2020

May 06, 2020

BUY
$32.37 - $59.36 $6.25 Million - $11.5 Million
192,953 New
192,953 $8.61 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.